Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?

The performance of twelve HIV combined p24 antigen and antibody assays available in Europe were compared. The assays were examined with a total of 1983 samples that included 1005 unselected HIV negative samples, 7 HIV-1 p24 Ag reference samples with HIV-1 Ag, 10 samples of a HIV antigen sensitivity commercial panel, 124 samples of 31 p24 antigen panels of different HIV-1 subtypes, 168 members of 24 HIV-1 seroconversion panels, 559 HIV-1 (groups M and O) antibody positive samples and 110 HIV-2 antibody positive samples. The specificity ranged from 99.4 to 100%. Ten of the 12 assays detected all anti-HIV positive samples irrespective of genotype while two assays missed one sample each (one subtype F and one subtype C). The combined assays could be classified into three groups. The first includes two assays (Enzygnost HIV Integral and Vironostika Ag/Ab) that have a clinical sensitivity similar to the two antibody only assays. The second includes the seven assays that detected infection after the p24 antigen only assay and show a delay from 3.3 to 5.17 days after HIV-1 RNA. The third group detected the infection before the p24 antigen assay and less than 3 days after nucleic acid testing (NAT). The improved ability to detect p24 Ag, at levels similar to specific HIV Ag assays, suggests that these new HIV combined Ag/Ab assays could replace p24 antigen only assays in situations for blood or organ screening when NAT is not feasible or not affordable.

[1]  C. Brennan,et al.  Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. , 2004, Journal of virological methods.

[2]  A. Vabret,et al.  Contribution of Combined Detection Assays of p24 Antigen and Anti-Human Immunodeficiency Virus (HIV) Antibodies in Diagnosis of Primary HIV Infection by Routine Testing , 2000, Journal of Clinical Microbiology.

[3]  B. Pozzetto,et al.  Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV. , 2005, Journal of virological methods.

[4]  H. Doerr,et al.  Reduction of Diagnostic Window by New Fourth-Generation Human Immunodeficiency Virus Screening Assays , 1998, Journal of Clinical Microbiology.

[5]  C. Brennan,et al.  Serologic and phylogenetic characterization of HIV‐1 subtypes in Uganda , 1997, AIDS.

[6]  H. Doerr,et al.  Evaluation of a New Combined Antigen and Antibody Human Immunodeficiency Virus Screening Assay, VIDAS HIV DUO Ultra , 2002, Journal of Clinical Microbiology.

[7]  W. Blattner,et al.  Fourth-Generation Enzyme-Linked Immunosorbent Assay for the Simultaneous Detection of Human Immunodeficiency Virus Antigen and Antibody , 2001, Journal of Clinical Microbiology.

[8]  M. Van de Graaf,et al.  Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II. , 1998, Journal of virological methods.

[9]  F. Donié,et al.  Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. , 1998, Journal of virological methods.

[10]  E. Knoll,et al.  Evidence for a diagnostic window in fourth generation assays for HIV. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  A. Moreau,et al.  Group O Human Immunodeficiency Virus Type 1 Infection That Escaped Detection in Two Immmunoassays , 2006, Journal of Clinical Microbiology.

[12]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[13]  S. Laperche,et al.  Les tests de dépistage combiné de l'antigène p24 et des anticorps anti-VIH dans l'infection précoce à VIH-I , 2000 .

[14]  G. Schochetman,et al.  Seven Human Immunodeficiency Virus (HIV) Antigen-Antibody Combination Assays: Evaluation of HIV Seroconversion Sensitivity and Subtype Detection , 2001, Journal of Clinical Microbiology.

[15]  S. Self,et al.  Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. , 2001, The Journal of infectious diseases.

[16]  G. Schochetman,et al.  Multicenter Evaluation of a New, Automated Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies and Antigen , 2004, Journal of Clinical Microbiology.

[17]  J. Desenclos,et al.  Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic , 2006, Journal of medical virology.

[18]  S. Laperche,et al.  Early Detection of Human Immunodeficiency Virus Infection Using Third- and Fourth-Generation Screening Assays , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[19]  A. Moreau,et al.  Subtype B Human Immunodeficiency Virus (HIV) Type 1 Mutant That Escapes Detection in a Fourth-Generation Immunoassay for HIV Infection , 2004, Journal of Clinical Microbiology.

[20]  A. Berger,et al.  Multicenter Evaluation of a New Automated Fourth-Generation Human Immunodeficiency Virus Screening Assay with a Sensitive Antigen Detection Module and High Specificity , 2002, Journal of Clinical Microbiology.

[21]  C. Brennan,et al.  Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays. , 2006, Journal of virological methods.

[22]  C. Rouzioux,et al.  Evaluation des trousses de dépistage de l'antigène p24 du VIH , 1997 .

[23]  C. Brennan,et al.  HIV global surveillance: Foundation for retroviral discovery and assay development , 2006, Journal of medical virology.

[24]  F. Fridinger,et al.  HIV antibody testing: who benefits and who loses? , 1989, Journal of health & social policy.

[25]  B. Söderquist,et al.  Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. , 2004, Clinical laboratory.

[26]  D. McElborough.  Importance of using an HIV Ag/Ab combined assay in a UK population at high risk of acquiring HIV infection. , 2004, Communicable disease and public health.

[27]  C. Mathiot,et al.  Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. , 1996, AIDS research and human retroviruses.